Su J, Zhu S, Liu Z, Zhao Y, Song C
Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Cancer Radiother. 2017 Feb;21(1):34-39. doi: 10.1016/j.canrad.2016.08.129. Epub 2016 Dec 29.
To compare the prognosis of elderly patients with early oesophageal carcinoma between radical elective nodal prophylactic irradiation and involved-field irradiation and to estimate the failure modes and adverse effects, then to provide the patients the safe and individual therapeutic regimens.
The charts of 96 patients aged 65 and over with early stage oesophageal carcinoma receiving radical radiotherapy in our department were retrospectively analysed. Of all the patients, 49 received elective nodal prophylactic irradiation and the other 47 received involved-field irradiation. After completion of the whole treatment, we analysed short-term effects, tumour local control, overall survival of the patients, failure modes and adverse effects.
The 1-, 3-, and 5-year local control rate in elective nodal irradiation and involved-field irradiation groups were 80.6%, 57.4%, 54.0% and 65.4%, 46.5%, 30.5% respectively, and the difference was statistically significant (χ=4.478, P=0.03). The differences of overall survival and progression-free survival were not significant (P>0.05). The difference of 1-, 3-, and 5-years local regional failure rate was statistically significant between elective nodal prophylactic irradiation and involved-field irradiation groups, except for the overall failure and distant metastasis rates. The overall incidence of radiation-induced oesophagitis after elective nodal irradiation or involved-field irradiation was 79.6% and 59.6%, and the difference was statistically significant (χ=4.559, P=0.03). The difference of radiation pneumonitis between elective nodal prophylactic irradiation and involved-field irradiation was not significant (12.2% vs 14.9%; χ=0.144, P=0.7).
For elderly patients with early stage oesophageal carcinoma receiving radical radiotherapy, although elective nodal prophylactic irradiation could increase the incidence of radiation-induced oesophagitis, patients could tolerate the treatment and benefit from local control.
比较老年早期食管癌患者行根治性选择性淋巴结预防性照射与累及野照射的预后,评估失败模式及不良反应,为患者提供安全个体化的治疗方案。
回顾性分析我科96例年龄≥65岁的早期食管癌患者接受根治性放疗的病历资料。其中49例行选择性淋巴结预防性照射,47例行累及野照射。完成全部治疗后,分析患者的近期疗效、肿瘤局部控制情况、总生存情况、失败模式及不良反应。
选择性淋巴结照射组与累及野照射组1年、3年、5年局部控制率分别为80.6%、57.4%、54.0%和65.4%、46.5%、30.5%,差异有统计学意义(χ=4.478,P=0.03)。总生存及无进展生存差异无统计学意义(P>0.05)。除总失败率及远处转移率外,选择性淋巴结预防性照射与累及野照射组1年、3年、5年局部区域失败率差异有统计学意义。选择性淋巴结照射或累及野照射后放射性食管炎总发生率分别为79.6%和59.6%,差异有统计学意义(χ=4.559,P=0.03)。选择性淋巴结预防性照射与累及野照射放射性肺炎差异无统计学意义(12.2%对14.9%;χ=0.144,P=0.7)。
对于接受根治性放疗的老年早期食管癌患者,虽然选择性淋巴结预防性照射会增加放射性食管炎的发生率,但患者可耐受该治疗并从局部控制中获益。